Repligen repligen.com

Repligen (NASDAQ:RGEN) is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. The company's bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. Repligen is a manufacturer of Protein A affinity ligands, a critical component of Protein A media that is used to separate and purify monoclonal antibody therapeutics.

Repligen (NASDAQ:RGEN) is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. The company's bioprocessing products are sold to major life sc...Show all

See All Exits Recent Exits

Phone: 781-250-0111

Fax:

41 Seyon Street
Building 1, Suite 100
Waltham, 02453
Massachusetts, United States

Repligen - Investments & Acquisitions

Show Real Data Repligen Investments
See all Recent Investments
Date Company Round Amount Co-investors
2017-08-24SpectrumAcquired
2017-08-05Spectrum PharmaceuticalsAcquired
2017-06-24Spectrum PharmaceuticalsAcq - P2P
2016-12-15TangenX TechnologyAcquired
2016-04-04AtollAcquired
See all 5 investments